Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Climate change is reshaping life on Earth at an unprecedented pace. Across the globe, species are shifting their ranges, altering migration routes and breeding earlier in the year in response to ...

The founder of Amazon, Jeff Bezos, does not often post on the social media site owned by his rival Elon Musk. But on Monday, Bezos did, sharing a black-and-white image of a turtle emerging from the ...

These reptiles have roamed the oceans for 100 million years. We've put them at risk, but with a little help, they're rebounding. Green sea turtles congregate near a dock in the Bahamas. They were so ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...